CD4 and neoplasm: Effective lymphoma immune surveillance using murine models was shown to be mediated by tumor-specific CD4+ T cells and associated with proinflammatory cytokines, particularly those that promote a TH1 phenotype including IFNγ, IL-2, and IL-12 (43).